期刊
CELL REPORTS
卷 27, 期 12, 页码 3629-+出版社
CELL PRESS
DOI: 10.1016/j.celrep.2019.05.061
关键词
-
类别
资金
- National Institutes of Health, United States [AI108651, AI123782, AI140095, AI112579, AI121080, AI139874, DK114427, AI139753]
- Juvenile Diabetes Research Foundation [2-SRA-2016-306-S-B]
- Veteran Affairs BLR&D Merit Review Program [BX002903A]
- Sun Yat-Sen University, Guangzhou, China
CD4(+) Foxp3(+) T regulatory (Treg) cells are key players in preventing lethal autoimmunity. Tregs undertake differentiation processes and acquire diverse functional properties. However, how Treg's differentiation and functional specification are regulated remains incompletely understood. Here, we report that gradient expression of TCF1 and LEF1 distinguishes Tregs into three distinct subpopulations, particularly highlighting a subset of activated Treg (aTreg) cells. Treg-specific ablation of TCF1 and LEF1 renders the mice susceptible to systemic autoimmunity. TCF1 and LEF1 are dispensable for Treg's suppressive capacity but essential for maintaining a normal aTreg pool and promoting Treg's competitive survival. As a consequence, the development of T follicular regulatory (Tfr) cells, which are a subset of aTreg, is abolished in TCF1/LEF1-conditional knockout mice, leading to unrestrained T follicular helper (Tfh) and germinal center B cell responses. Thus, TCF1 and LEF1 act redundantly to control the maintenance and functional specification of Treg subsets to prevent autoimmunity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据